non-Hodgkin's lymphoma with poor prognosis. N E J M 1987; 
! 316:1499-1505. 
45. Negrin RS, Blume KG. The use of the polymerase chain 
reaction for the detection of minimal residual malignant disease. 
Blood 1991; 78:255-258. 
46. Graham-Pole J, Gee A, Emerson S, et al. Myeloablative 
chemoradiotherapy and autologus bone marrow infusions for 
treatment of neuroblastoma: factors influencing engraftment. 
Blood 1991; 78:1607-1614. 
j 
47. Elias A, Mazanet R, Wheeler C, et al. Peripheral blood 
| progenitor cells (pbpc) : two protocols using GM-CSF potentiated 
progenitor cell collection. In: Dicke K, Armitage JO, 
Dicke-Evinger MJ, eds. Autologous Bone Marrow Transplantation: 
Proceedings of the Fifth International Symposium. Omaha: 
University of Nebraska, 1991:875-879. 
48. Kessinger A. Autologous transplantation with peripheral 
blood stem cells: a review of clinical results. J Clin Apheresis 
1990; 5:97-99. 
Recombinant DNA Research, Volume 16 
[179] 
